Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Galectin Therapeutics Inc (NASDAQ:GALT)

2.46
Delayed Data
As of Jun 23
 +0.08 / +3.36%
Today’s Change
0.49
Today|||52-Week Range
3.68
+151.07%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash10.5M29.1M25.9M15.4M
 
 
 
 
 
Short Term Investment Cash1.1M18.6M-3.3M-10.5M
 
 
 
 
 
Cash & Short Term Investments10.5M29.1M25.9M15.4M
 
 
 
 
 
 
ReceivablesReceivables----0.000.00--
 
InventoriesInventories0.00--0.000.00--
 
Current AssetsOther Current Assets198.0K527.0K548.0K432.0K
 
 
 
 
 
Current Assets10.7M29.7M26.4M15.8M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross74.0K74.0K74.0K74.0K
 
 
 
 
 
Depreciation-71.0K-73.0K-74.0K-74.0K
 
 
 
 
 
Intangible Assets23.0K15.0K8.0K1.0K
 
 
 
 
 
Other Assets23.0K15.0K8.0K1.0K
 
 
 
 
 
Total Assets10.7M29.7M26.4M15.8M
 
 
 
 
 
 
LiabilitiesAccounts Payable762.0K0.000.000.00
 
 
Accrued Expenses1.1M125.0K219.0K2.2M
 
 
 
 
 
Other Current Liabilities1.1M1.0M667.0K3.1M
 
 
 
 
 
Other Liabilities2.5M1.7M1.4M3.8M
 
 
 
 
 
 
Total LiabilitiesTotal Liabilities2.5M1.7M1.4M3.8M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock7.3M7.3M7.6M9.0M
 
 
 
 
 
Common Equity894.0K20.6M17.5M3.1M
 
 
 
 
 
Total Shareholder Equity8.2M28.0M25.0M12.0M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding18.4M22.3M28.8M32.9M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.